Your session is about to expire
← Back to Search
Domperidone for Gastroparesis and Acid Reflux
Study Summary
This trial program will allow the use of domperidone in children with motility disorders and GERD who have failed standard treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not taking any drugs or supplements listed as risky in the trial's addendum.I have noticed changes in my breast.I have side effects from medication that affect my body movements.I have signed a consent form understanding the risks of taking domperidone, including heart issues and breast changes.You have important problems with the minerals in your body.I have severe GERD symptoms or stomach issues not relieved by standard treatments.I have had bleeding or blockage in my digestive tract.I have a tumor in my pituitary gland that releases prolactin.I understand the risks of certain medications and supplements and will consult before using them.You are allergic to domperidone.I have a slow heartbeat or heart rhythm issue, and my QTc interval is longer than normal.I have a history of serious heart rhythm problems but not minor irregular heartbeats.I have severe GERD symptoms or stomach issues not relieved by standard treatments.Before joining the study, patients need to undergo a thorough examination to rule out other reasons for their symptoms.I am between 12 and 21 years old.
- Group 1: Overall Study
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What conditions are usually treated using this therapeutic approach?
"This treatment is chiefly applied to address upper gastrointestinal motility disorders. Additionally, it has been administered to patients with esophagitis, gastroesophageal reflux disease and gastroparesis."
Does this experiment accept participants aged thirty years or younger?
"According to the inclusion criteria, only those between 12 and 21 are eligible for participation. Furthermore, there are 19 trials aimed at minors while 90 trials focus on senior citizens."
What is the uppermost limit of participants in this experiment?
"Affirmative. Per the information found on clinicaltrials.gov, this research study is actively recruiting individuals as of May 17th 2022 and first began doing so on April 1st 2013. Currently they are enrolling 20 patients at a single location."
Are there still vacancies for this experiment in medicine?
"According to the data available at clinicaltrials.gov, this medical study is actively searching for qualified volunteers since it was first made public on April 1st 2013 and last updated on May 17th 2022."
Have any prior experiments been conducted to investigate this therapy?
"Currently, four studies are underway attempting to assess this remedy. One of the inquiries is presently in its third stage. While most investigations into this therapy take place in Bangkok, there are 4 separate sites running experiments with it."
Does my profile fulfill the criteria for participation in this experiment?
"In order to be eligible for this medical trial, patients must fall between the ages of 12 and 21 and have been diagnosed with gastroesophageal reflux. Altogether, 20 individuals are being recruited in total."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger